1-3 of 3
L. Melillo, MD
Close
Sort by
Journal Articles

Intermediate Dose Melphalan, Bortezomib, Thalidomide, Dexametasone (MVTD) Conditioning Therapy and ASCT in Relapsed Multiple Myeloma Patients: A Single Center Experience.

Potito Rosario Scalzulli, MD, Maria Rosa Valvano, SD, Carlo C. Bodenizza, MD, Angelo Michele Carella, MD, Matteo M. Dell’Olio, MD, Antonietta A.P. Falcone, MD, Michele Mario Greco, MD, Antonio A. La Sala, MD, Francesco F.S. Mantuano, MD, Lorella L. Melillo, MD, Emanuela E. Merla, MD, Michele M. Nobile, MD, Sanpaolo G. Sanpaolo, MD, Nicola N. Cascavilla, MD
Journal: Blood
Blood (2007) 110 (11): 5117.
https://doi.org/10.1182/blood.V110.11.5117.5117
Published: 2007
Journal Articles

Therapy-Related Myelodysplastic Syndrome (sMDS) /Acute Myelogenous Leukemia (sAML) in Acute Promyelocytic Leukemia (APL) Patients with Long-Lasting Molecular Remission: The GIMEMA Experience.

R. Latagliata, MD, M. Breccia, MD, P. Fazi, MD, S. Gubbiotti, MD, E. Di Bona, MD, G. Specchia, PhD, A. Chiarenza, MD, R. Murru, MD, A.M. Carella, PhD, F. Ferrara, PhD, G. Rossi, MD, L. Melillo, MD, S. Sica, MD, R. Invernizzi, MD, G. Cimino, PhD, M.C. Petti, PhD, G. Avvisati, PhD, F. Lo-Coco, PhD, F. Mandelli, PhD
Journal: Blood
Blood (2005) 106 (11): 884.
https://doi.org/10.1182/blood.V106.11.884.884
Published: 2005
Journal Articles

Long-Term Results of the GIMEMA LAP AIDA 0493 Amended Protocol in Elderly Patients with Acute Promyelocytic Leukemia (APL).

R. Latagliata, MD, M. Breccia, MD, P. Fazi, MD, M. Vignetti, MD, A. Cupri, MD, M. Sborgia, MD, D. Vincelli, MD, A. Candoni, MD, F. Salvi, MD, S. Rupoli, MD, G. Martinelli, MD, M.G. Kropp, MD, N. Di Rienzo, MD, V. Zampaglione, MD, A. Venditti, PhD, L. Melillo, MD, G. Cimino, PhD, M.C. Petti, MD, G. Avvisati, PhD, F. Lo Coco, PhD, F. Mandelli, PhD
Journal: Blood
Blood (2005) 106 (11): 885.
https://doi.org/10.1182/blood.V106.11.885.885
Published: 2005